Feiwu Ran

2PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 21, 2026
Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non-Small Cell Lung Cancer: Results From the Phase II TRUST-I Study.

|Apr 03, 2025
Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST.

Maurice Pérol, Wei Li, Nathan A Pennell

Pageof 1